Page last updated: 2024-10-25

diazepam and Acute Myelogenous Leukemia

diazepam has been researched along with Acute Myelogenous Leukemia in 1 studies

Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaleff, S1
Hurwitz, CA1
Chang, M1
Dahl, G1
Alonzo, TA1
Weinstein, H1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase IV, Randomized Study to Evaluate the Safety and Efficacy of Idarubicin at Different Dosages Combined With Cytarabine as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia[NCT02277847]Phase 4400 participants (Anticipated)Interventional2010-03-31Enrolling by invitation
Idarubicin and Cladribine in Recurrent and Refractory Acute Myeloid Leukemia: A POG Phase II Study[NCT00003178]Phase 2120 participants (Actual)Interventional1998-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for diazepam and Acute Myelogenous Leukemia

ArticleYear
Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study.
    British journal of haematology, 2012, Volume: 156, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Child; Diazepam; Diseas

2012
Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study.
    British journal of haematology, 2012, Volume: 156, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Child; Diazepam; Diseas

2012
Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study.
    British journal of haematology, 2012, Volume: 156, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Child; Diazepam; Diseas

2012
Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study.
    British journal of haematology, 2012, Volume: 156, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Child; Diazepam; Diseas

2012